Search research articles
Contact Us
Filters
Showing results (171-180 of 225) with videos related to
Page
of 23
Sort By:
Genetic Counseling (Geneva, Switzerland)
|
July 16, 2008
Tumoral calcinosis due to GALNT3 C.516-2A >T mutation in a black African family
A Laleye, M J Alao, G Gbessi, et al.
Human Molecular Genetics
|
March 1, 1996
Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease
J Amiel, T Attié, D Jan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
G Giaccone, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
P Schöffski, S Riggert, P Fumoleau, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
Clinical Genetics
|
August 23, 2006
Mosaic maternal uniparental isodisomy for chromosome 7q21-qter
M-P Reboul, O Tandonnet, N Biteau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)
C M L van Herpen, L D Locati, J Buter, et al.
Investigational New Drugs
|
May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors
M J A de Jonge, J P Droz, L Paz-Ares, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 25, 2000
Statistical analysis of mitochondrial pathologies in childhood: identification of deficiencies using principal component analysis
T Letellier, G Durrieu, M Malgat, et al.
Human Mutation
|
October 26, 1999
Townes-Brocks syndrome: detection of a SALL1 mutation hot spot and evidence for a position effect in one patient
S Marlin, S Blanchard, R Slim, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 225) with videos related to
Sort By:
Page
of 23
Genetic Counseling (Geneva, Switzerland)
|
July 16, 2008
Tumoral calcinosis due to GALNT3 C.516-2A >T mutation in a black African family
A Laleye, M J Alao, G Gbessi, et al.
Human Molecular Genetics
|
March 1, 1996
Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease
J Amiel, T Attié, D Jan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
G Giaccone, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
P Schöffski, S Riggert, P Fumoleau, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
Clinical Genetics
|
August 23, 2006
Mosaic maternal uniparental isodisomy for chromosome 7q21-qter
M-P Reboul, O Tandonnet, N Biteau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)
C M L van Herpen, L D Locati, J Buter, et al.
Investigational New Drugs
|
May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors
M J A de Jonge, J P Droz, L Paz-Ares, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 25, 2000
Statistical analysis of mitochondrial pathologies in childhood: identification of deficiencies using principal component analysis
T Letellier, G Durrieu, M Malgat, et al.
Human Mutation
|
October 26, 1999
Townes-Brocks syndrome: detection of a SALL1 mutation hot spot and evidence for a position effect in one patient
S Marlin, S Blanchard, R Slim, et al.
Page
of 23